These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 13920455)

  • 1. [Drug prices,public opinion, legal measures].
    TEUNISSEN HP
    Pharm Weekbl; 1962 May; 97():425-32. PubMed ID: 13920455
    [No Abstract]   [Full Text] [Related]  

  • 2. Problematic Jumps in Drug Prices and What You Can Do.
    Shaughnessy AF
    Am Fam Physician; 2017 Jul; 96(1):16-18. PubMed ID: 28671371
    [No Abstract]   [Full Text] [Related]  

  • 3. PUBLIC attitudes toward prescription costs and the drug industry. Part III. Public attitudes toward the drug manufacturers.
    SD J Med Pharm; 1960 Sep; 13():486-91. PubMed ID: 13858299
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug industry is now biggest defrauder of US government.
    Braillon A
    BMJ; 2012 Jan; 344():d8219. PubMed ID: 22235007
    [No Abstract]   [Full Text] [Related]  

  • 5. The drug industry. The public image.
    Smith T
    Br Med J; 1980 Nov; 281(6252):1410-1. PubMed ID: 7437816
    [No Abstract]   [Full Text] [Related]  

  • 6. Scandals have eroded US public's confidence in drug industry.
    Lenzer J
    BMJ; 2004 Jul; 329(7460):247. PubMed ID: 15284128
    [No Abstract]   [Full Text] [Related]  

  • 7. Ensuring public trust.
    Insel TR; Fenton WS
    Biol Psychiatry; 2004 Oct; 56(8):539. PubMed ID: 15476681
    [No Abstract]   [Full Text] [Related]  

  • 8. Puzzling industry response to ProdiGene fiasco.
    Fox JL
    Nat Biotechnol; 2003 Jan; 21(1):3-4. PubMed ID: 12511893
    [No Abstract]   [Full Text] [Related]  

  • 9. Building legitimacy by criticising the pharmaceutical industry: a qualitative study among prescribers and local opinion leaders.
    Pittet AL; Saraga M; Stiefel F
    Swiss Med Wkly; 2015; 145():w14240. PubMed ID: 26661626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open letter (and invitation) to the pharmaceutical industry: "no, we cannot just present your slide deck …".
    Benbadis SR; Faught RE; Hirsch L; Sperling M; Slater J; Sirven J
    Epilepsy Behav; 2010 Nov; 19(3):544-5. PubMed ID: 20833110
    [No Abstract]   [Full Text] [Related]  

  • 11. New image for the drug industry.
    Cohen D
    BMJ; 2011 Nov; 343():d7713. PubMed ID: 22127772
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug industry--physicians--society].
    Slettevold L
    Tidsskr Nor Laegeforen; 1998 Mar; 118(8):1242-3. PubMed ID: 9567703
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug chiefs ponder how to improve industry's reputation.
    Burton B
    BMJ; 2005 May; 330(7502):1229. PubMed ID: 15920122
    [No Abstract]   [Full Text] [Related]  

  • 14. Restoring confidence in the pharmaceutical industry.
    Bauchner H; Fontanarosa PB
    JAMA; 2013 Feb; 309(6):607-9. PubMed ID: 23403686
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulating the pharmaceutical industry. General public does not support value system inherent in cost effectiveness analyses.
    Furniss J; Zammit-Lucia J; Johnson N
    BMJ; 1998 Jan; 316(7126):226; author reply 228. PubMed ID: 9468699
    [No Abstract]   [Full Text] [Related]  

  • 16. Attitudes of physicians and public to pharmaceutical industry 'gifts'.
    Macneill PU; Kerridge IH; Newby D; Stokes BJ; Doran E; Henry DA
    Intern Med J; 2010 May; 40(5):335-41. PubMed ID: 20345507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients and the public deserve big changes in evaluation of drugs.
    Garattini S; Chalmers I
    BMJ; 2009 Mar; 338():b1025. PubMed ID: 19336489
    [No Abstract]   [Full Text] [Related]  

  • 18. [Not Available].
    Sauerteig L
    Med Ges Gesch Beih; 1996; 9():161-200. PubMed ID: 11636505
    [No Abstract]   [Full Text] [Related]  

  • 19. Democracy unleashed--unpacking the tooth fairy in drug industry R&D.
    Ozdemir V; Williams-Jones B
    Nat Biotechnol; 2006 Nov; 24(11):1324-6; author reply 1326-7. PubMed ID: 17093467
    [No Abstract]   [Full Text] [Related]  

  • 20. Proposal to allow drug companies to give information to public sparks outcry.
    Watson R
    BMJ; 2008 Dec; 337():a3043. PubMed ID: 19088139
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.